Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
---|
10/05/2010 | US7807142 comprising interleukin-2 (IL-2); using an amino acid base sufficient to decrease aggregate formation of the polypeptide during storage of the composition, and a buffering agent ; mixture with amino acid and buffer |
10/05/2010 | CA2456519C Oral compositions for the treatment of scalp disorders |
10/05/2010 | CA2436233C Perylenequinones for use with immunotherapy agents |
10/05/2010 | CA2407967C Tubulin binding ligands and corresponding prodrug constructs |
10/05/2010 | CA2393297C Polyhydroxystilbenes as antipsoriatic agents and protein kinase inhibitors |
10/05/2010 | CA2367138C Anti-inflammatory uses of manzamines |
09/30/2010 | WO2010111719A2 Melanogenesis inhibition by 3, 5-dimethoxy-4'-hydroxystilbenes and cosmeceutical compositions thereof |
09/30/2010 | WO2010111374A2 Compositions and methods for alleviating skin disorders |
09/30/2010 | WO2010111108A2 Compositions and methods for the treatment of wounds |
09/30/2010 | WO2010110479A1 Activator for peroxisome proliferator-activated receptor |
09/30/2010 | WO2010110428A1 Prophylactic and/or therapeutic agent for pruritus |
09/30/2010 | WO2010110220A1 Dispersion and manufacturing method therefor |
09/30/2010 | WO2010109434A2 A medicinal antibacterial, antifungal and steroids cream and a process to make it |
09/30/2010 | WO2010109424A1 A medicinal antibacterial and steroids cream comprising chitosan and a process to make it |
09/30/2010 | WO2010109423A1 A medicinal antifungal and steroids cream comprising chitosan and a process to make it |
09/30/2010 | WO2010109421A1 A medicinal antifungal and steroids cream comprising chitosan and a process to make it |
09/30/2010 | WO2010109420A1 A medicinal anti acne cream comprising chitosan and a process to make it |
09/30/2010 | WO2010034011A9 Phenylthiophenyldihydrobenzothiazepine inhibitors of store operated calcium release |
09/30/2010 | US20100249244 Methods and compositions for treating dermatological diseases and conditions |
09/30/2010 | US20100249236 Adhesive and plaster |
09/30/2010 | US20100249222 Methods of treating skin with aromatic skin-active ingredients |
09/30/2010 | US20100249218 Method to inhibit cell growth using oligonucleotides |
09/30/2010 | US20100249202 Agent for fungal dermatitis |
09/30/2010 | US20100249198 (r)-4-(heteroaryl) phenylethyl derivatives and pharmaceutical compositions containing them |
09/30/2010 | US20100249197 Carbamic acid compounds comprising an amide linkage as hdac inhibitors |
09/30/2010 | US20100249183 Therapeutic use of n-(arylalkyl)-1h-pyrrolopyridine-2-carboxamide derivatives |
09/30/2010 | US20100249174 Ccr1 antagonists and methods of use therefor |
09/30/2010 | US20100249168 Compounds and Formulations Suitable for Radical Scavenging |
09/30/2010 | US20100249155 Atropisomers of 2-purinyl-3-tolyl-quinazolinone derivatives and methods of use |
09/30/2010 | US20100249128 Novel 3-amido-pyrrolo[3,4-c]pyrazole-5(1h,4h,6h) carbaldehyde derivatives |
09/30/2010 | US20100249118 Compounds and methods for kinase modulation, and indications therefor |
09/30/2010 | US20100249106 Methods of Making and Using Therapeutically Active Thiophenepyrimidinone Compounds |
09/30/2010 | US20100249092 Heteroaryl compounds and uses thereof |
09/30/2010 | US20100249085 Heteroaryl substituted pyrazole derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
09/30/2010 | US20100249080 Personal care composition |
09/30/2010 | US20100249078 Tetracyclic inhibitors of fatty acid amide hydrolase |
09/30/2010 | US20100249071 Modulators of S1P and Methods of Making And Using |
09/30/2010 | US20100249060 Topical formulation of low level clobetasol propionate for treating disorders of the skin and mucous membranes |
09/30/2010 | US20100249044 Biogel |
09/30/2010 | US20100249043 Compositions and methods for promoting hair growth |
09/30/2010 | US20100249041 Compositions comprising ornithine ketoglutarate (okg) |
09/30/2010 | US20100249035 Peptides, compositions and uses thereof |
09/30/2010 | US20100249034 Gfralpha3 and its uses |
09/30/2010 | US20100249032 Human EPO Mimetic Hinge Core Mimetibodies, Compositions, Methods and Uses |
09/30/2010 | US20100247693 Cosmetic formulation to treat rosacea telangiectasia |
09/30/2010 | US20100247691 Anti-angiogenic agents and anti-obesity substances applied with anti-angiogenesis from natural products |
09/30/2010 | US20100247690 Composition for prevention and/or treatment of pruritus containing acacai bark derivative |
09/30/2010 | US20100247689 Agent containing fat (oil), which contains onion extract, the production and use thereof for caring, preventing or treating damaged skin tissue, especially scarred tissue |
09/30/2010 | US20100247680 Compositions and Methods to Modulate Angiogenesis |
09/30/2010 | US20100247663 Microspheres |
09/30/2010 | US20100247631 Preparations for the external application of antiseptic agents and/or agents promoting the healing of wounds |
09/30/2010 | US20100247628 Skin Treatment Compositions Containing Copper-Pigment Complexes |
09/30/2010 | US20100247627 Foxn1 and pigmentation |
09/30/2010 | US20100247614 Hemostatic wound dressing |
09/30/2010 | US20100247591 Skin Treatment Compositions Containing Copper-Pigment Complexes |
09/30/2010 | US20100247590 Peptide-Based Systems For Delivery Of Cosmetic Agents |
09/30/2010 | US20100247587 Pigmentation-regulating compounds |
09/30/2010 | US20100247583 Novel n-phenylacetamide inhibitors of the enzyme soat-1 and pharmaceutical/cosmetic compositions comprised thereof |
09/30/2010 | US20100247544 Compositions and Methods for Promoting the Healing of Tissue of Multicellular Organisms |
09/30/2010 | US20100247540 Methods and Compositions For Modulating Angiogenesis |
09/30/2010 | US20100247523 Subtypes of humanized antibody against interleuken-6 receptor |
09/30/2010 | US20100247520 Mutated netrin 4, fragments thereof and uses thereof as drugs |
09/30/2010 | US20100247518 Modified proteins, designer toxins, and methods of making thereof |
09/30/2010 | US20100247471 Phenoxy-pyrrolidine derivative and its use and compositions |
09/30/2010 | US20100247468 Compounds that modulate PPAR gamma-type receptors and cosmetic/pharmaceutical compositions comprising said compounds |
09/30/2010 | US20100247463 N-(phosphonoalkyl)-amino acids, derivatives thereof and compositions and methods of use |
09/30/2010 | US20100247461 Anti-inflammatory complexes |
09/30/2010 | US20100247454 Compositions for elastogenesis and connective tissue treatment |
09/30/2010 | US20100247451 Use of erythropoietin |
09/30/2010 | US20100247450 Use of erythropoietin |
09/30/2010 | US20100247449 Foamable composition essentially free of pharmaceutically active ingredients for the treatment of human skin |
09/30/2010 | US20100247443 Effectiveness evaluating method, effectiveness evaluating device, and effectiveness evaluating program for external preparation for skin |
09/30/2010 | US20100247434 Anti-Angiogenic Extracts from Pomegranate |
09/30/2010 | US20100247428 Uses of rare earth elements for hair improvement |
09/30/2010 | CA2756316A1 Methods for preventing and treating radiation-induced epithelial disorders |
09/29/2010 | EP2233486A1 Azaindoles |
09/29/2010 | EP2233483A1 Indole or Benzimidazole derivatives as IkB-kinase modulators and intermediates in their preparation. |
09/29/2010 | EP2233154A1 Skin external preparation |
09/29/2010 | EP2233150A2 Erythropoietin for use in the treatment of wounds or the transplantation of cells |
09/29/2010 | EP2233144A1 Chitosan-containing compositions and process for production thereof |
09/29/2010 | EP2231708A1 Remedies for pemphigus containing anti fas ligand antobodies |
09/29/2010 | EP2231652A1 Novel 2-hetaryl thiazole-4-carboxamide derivatives, production thereof, and use thereof as a medicament |
09/29/2010 | EP2231595A1 Phenyl acetic acid derivatives as inflammation modulators |
09/29/2010 | EP2231178A1 Methods for inhibiting scarring |
09/29/2010 | EP2231174A1 Use larch wood material for treating inflammation |
09/29/2010 | EP2231164A1 Oxysterols for activation of hedgehog signaling, osteoinduction, antiadipogenesis, and wnt signaling |
09/29/2010 | EP2231139A2 Therapeutic formulations based on asiatic acid and selected salts thereof |
09/29/2010 | EP1446136B1 Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
09/29/2010 | CN1872261B Drop pills of fine powder of dragons blood, and preparation method |
09/29/2010 | CN1868505B 蛇胆粉胶囊 Snake Powder Capsules |
09/29/2010 | CN1857515B Skin care Chinese medicine film preparation and its preparing process |
09/29/2010 | CN1810777B Compound for preventing and treating bacterial infection and its preparation and use |
09/29/2010 | CN1695740B Composite body of fiber protein adhesive and antibiotics in use for treating infection in deep part, and application |
09/29/2010 | CN101848739A Surgical hydrogel |
09/29/2010 | CN101848714A Remedy for relieving skin troubles comprising morphinan derivative or pharmacologically acceptable acid addition salt thereof as the active ingredient |
09/29/2010 | CN101848713A Oral preparation comprising specific organic acid, and method for improvement in elution property and chemical stability of oral preparation |
09/29/2010 | CN101845383A Earth knee Health care wine |
09/29/2010 | CN101843895A Cytokine receptor ZCYTOR17 multimers |
09/29/2010 | CN101843889A Medicament for treating lymphedema and venous edema and application thereof |
09/29/2010 | CN101843871A Chinese medicament for treating diabetic acro-necrosis |